These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 14512700)
1. Effect of ketotifen on the production of reactive oxygen species from human eosinophils primed by eotaxin. Yamada Y; Sannohe S; Saito N; Cui CH; Ueki S; Oyamada H; Kanda A; Yamaguchi K; Hamada K; Adachi T; Kayaba H; Chihara J Pharmacology; 2003 Nov; 69(3):138-41. PubMed ID: 14512700 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of ketotifen on eotaxin-dependent activation of eosinophils: consequences for allergic eye diseases. Woerly G; Loiseau S; Loyens M; Schoch C; Capron M Allergy; 2003 May; 58(5):397-406. PubMed ID: 12752326 [TBL] [Abstract][Full Text] [Related]
3. Eosinophil activation by eotaxin--eotaxin primes the production of reactive oxygen species from eosinophils. Honda K; Chihara J Allergy; 1999 Dec; 54(12):1262-9. PubMed ID: 10688429 [TBL] [Abstract][Full Text] [Related]
4. Effect of eotaxin on the generationof reactive oxygen species from eosinophil cell line, YY-1. Honda K; Yamada Y; Cui C; Saito N; Kayaba H; Kobayashi Y; Oyamada H; Kamada Y; Kuwasaki T; Tsurufuji S; Chihara J Int Arch Allergy Immunol; 1999; 120 Suppl 1():48-50. PubMed ID: 10529604 [TBL] [Abstract][Full Text] [Related]
5. Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis. Sannohe S; Adachi T; Hamada K; Honda K; Yamada Y; Saito N; Cui CH; Kayaba H; Ishikawa K; Chihara J Eur Respir J; 2003 Jun; 21(6):925-31. PubMed ID: 12797483 [TBL] [Abstract][Full Text] [Related]
6. Regulatory effects of eotaxin, eotaxin-2, and eotaxin-3 on eosinophil degranulation and superoxide anion generation. Badewa AP; Hudson CE; Heiman AS Exp Biol Med (Maywood); 2002 Sep; 227(8):645-51. PubMed ID: 12192108 [TBL] [Abstract][Full Text] [Related]
7. Effect of roxithromycin on eotaxin-primed reactive oxygen species from eosinophils. Cui CH; Honda K; Saito N; Yamada Y; Sannohe S; Ueki S; Hamada K; Yamaguchi K; Kobayashi Y; Adachi T; Kayaba H; Chihara J Int Arch Allergy Immunol; 2001; 125 Suppl 1():38-41. PubMed ID: 11408771 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of oxatomide on oxygen-radical generation and peptide-leukotriene release from guinea pig eosinophils. Ohmori K; Manabe H; Akuta-Ohnuma K Arzneimittelforschung; 1998 Jan; 48(1):43-6. PubMed ID: 9522030 [TBL] [Abstract][Full Text] [Related]
9. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate. Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370 [TBL] [Abstract][Full Text] [Related]
10. Anti-allergic properties of the bromeliaceae Nidularium procerum: inhibition of eosinophil activation and influx. Vieira-de-Abreu A; Amendoeira FC; Gomes GS; Zanon C; Chedier LM; Figueiredo MR; Kaplan MA; Frutuoso VS; Castro-Faria-Neto HC; Weller PF; Bandeira-Melo C; Bozza PT Int Immunopharmacol; 2005 Dec; 5(13-14):1966-74. PubMed ID: 16275631 [TBL] [Abstract][Full Text] [Related]
11. Interactions between eotaxin and interleukin-5 in the chemotaxis of primed and non-primed human eosinophils. Costa GG; Silva RM; Franco-Penteado CF; Antunes E; Ferreira HH Eur J Pharmacol; 2007 Jul; 566(1-3):200-5. PubMed ID: 17368616 [TBL] [Abstract][Full Text] [Related]
12. Effect of emedastine difumarate on CC chemokine-elicited eosinophil migration. Saito H; Yamamoto N; Tomita S; Taniguchi M; Hasegawa M; Akiyama K; Kawaguchi H; Takahashi K Int Arch Allergy Immunol; 2001; 125 Suppl 1():22-8. PubMed ID: 11408768 [TBL] [Abstract][Full Text] [Related]
13. Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils. Elsner J; Petering H; Kluthe C; Kimmig D; Smolarski R; Ponath P; Kapp A Eur J Immunol; 1998 Jul; 28(7):2152-8. PubMed ID: 9692884 [TBL] [Abstract][Full Text] [Related]
14. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils. Dulkys Y; Schramm G; Kimmig D; Knöss S; Weyergraf A; Kapp A; Elsner J J Invest Dermatol; 2001 Apr; 116(4):498-505. PubMed ID: 11286614 [TBL] [Abstract][Full Text] [Related]
15. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Elsner J; Höchstetter R; Kimmig D; Kapp A Eur J Immunol; 1996 Aug; 26(8):1919-25. PubMed ID: 8765040 [TBL] [Abstract][Full Text] [Related]
16. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3. Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of N-acetylcysteine on the functional responses of human eosinophils in vitro. Martinez-Losa M; Cortijo J; Juan G; O'Connor JE; Sanz MJ; Santangelo F; Morcillo EJ Clin Exp Allergy; 2007 May; 37(5):714-22. PubMed ID: 17456219 [TBL] [Abstract][Full Text] [Related]
18. Effects of reactive oxygen and nitrogen metabolites on eotaxin-induced eosinophil chemotactic activity in vitro. Sato E; Simpson KL; Grisham MB; Koyama S; Robbins RA Am J Respir Cell Mol Biol; 2000 Jan; 22(1):61-7. PubMed ID: 10615066 [TBL] [Abstract][Full Text] [Related]
20. Beta2-integrin adhesion caused by eotaxin but not IL-5 is blocked by PDE-4 inhibition and beta2-adrenoceptor activation in human eosinophils. Liu J; Muñoz NM; Meliton AY; Zhu X; Lambertino AT; Xu C; Myo S; Myou S; Boetticher E; Johnson M; Leff AR Pulm Pharmacol Ther; 2004; 17(2):73-9. PubMed ID: 15123228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]